Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NMT Medical/Integra Lifesciences

This article was originally published in The Gray Sheet

Executive Summary

NMT's divestiture of the Selector ultrasonic aspirator, Ruggles surgical instruments and cryosurgery product lines to Integra LifeSciences for $12 mil. will enable the firm to refocus on its core cardiovascular business, the firm announces March 21. The product lines generated 1999 revenues of approximately $12.1 mil. In connection with the acquisition, Integra will change the name of its neurosurgical device business from Integra NeuroCare to Integra NeuroSciences, expand its direct sales force focusing on neurotrauma and neurosurgery to 45 U.S. reps, and build sales forces in the U.K. and Ireland

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013164

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel